Prediagnostic expressions in health records predict mortality in Parkinson's disease: A proof-of-concept study

被引:3
|
作者
Kuusimaki, Tomi [1 ,2 ]
Sainio, Jani [3 ,4 ]
Kurki, Samu [3 ,4 ]
Vahlberg, Tero [5 ]
Kaasinen, Valtteri [1 ,2 ]
机构
[1] Univ Turku, Clin Neurosci, Turku, Finland
[2] Turku Univ Hosp, Neuroctr, Hameentie 11,POB 52, FIN-20521 Turku, Finland
[3] Univ Turku, Auria Biobank, Turku, Finland
[4] Turku Univ Hosp, Turku, Finland
[5] Univ Turku, Dept Biostat, Turku, Finland
关键词
Parkinson 's disease; Prodromal; Data mining; Electronical health records; Mortality; Prognosis; MOTOR; RISK; ASSOCIATION; DEPRESSION; SURVIVAL; FEATURES; CRITERIA;
D O I
10.1016/j.parkreldis.2021.12.015
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction: The relationship of prodromal markers of PD with PD mortality is unclear. Electronic health records (EHRs) provide a large source of raw data that could be useful in the identification of novel relevant prognostic factors in PD. We aimed to provide a proof of concept for automated data mining and pattern recognition of EHRs of PD patients and to study associations between prodromal markers and PD mortality. Methods: Data from EHRs of PD patients (n = 2522) were collected from the Turku University Hospital database between 2006 and 2016. The data contained >27 million words/numbers and >750000 unique expressions. The 5000 most common words were identified in three-year time period before PD diagnosis. Cox regression was used to investigate the association of expressions with the 5-year survival of PD patients. Results: During the five-year period after PD diagnosis, 839 patients died (33.3%). If expressions associated with psychosis/hallucinations were identified within 3 years before the diagnosis, worse survival was observed (hazard ratio = 1.71, 95%CI = 1.46-1.99, p < 0.001). Similar effects were observed for words associated with cognition (1.23, 1.05-1.43, p = 0.009), constipation (1.34, 1.15-1.56, p = 0.0002) and pain (1.34, 1.12-1.60, p = 0.001). Conclusions: Automated mining of EHRs can predict relevant clinical outcomes in PD. The approach can identify factors that have previously been associated with survival and detect novel associations, as observed in the link between poor survival and prediagnostic pain. The significance of early pain in PD prognosis should be the focus of future studies with alternate methods.
引用
收藏
页码:35 / 39
页数:5
相关论文
共 50 条
  • [21] Mortality in Parkinson's Disease: A 20-Year Follow-Up Study
    Diem-Zangerl, Anja
    Seppi, Klaus
    Wenning, Gregor K.
    Trinka, Eugen
    Ransmayr, Gerhard
    Oberaigner, Wilhelm
    Poewe, Werner
    MOVEMENT DISORDERS, 2009, 24 (06) : 819 - 825
  • [22] Mortality from Parkinson's disease: A population-based prospective study (NEDICES)
    Posada, Ignacio J.
    Benito-Leon, Julian
    Louis, Elan D.
    Trincado, Rocio
    Villarejo, Alberto
    Jose Medrano, Maria
    Bermejo-Pareja, Felix
    MOVEMENT DISORDERS, 2011, 26 (14) : 2522 - 2529
  • [23] Mortality from Parkinson's disease in China: Findings from a ten-year follow up study in Shanghai
    Zhang, Yueqi
    Wang, Chunfang
    Wang, Ying
    Xiao, Qin
    Liu, Jun
    Ma, Jianfang
    Zhou, Haiyan
    Pan, Jing
    Tan, Yuyan
    Chen, Shengdi
    Xu, Gang
    Wang, Gang
    PARKINSONISM & RELATED DISORDERS, 2018, 55 : 75 - 80
  • [24] Land- and water-based sports activities in natural environments as a group exercise for Parkinson's disease: proof-of-concept pilot study
    Meloni, Martina
    Natale, Davide
    Caria, Alessandra
    Porco, Ilaria Giuseppina
    Ventura, Lucia
    Di Blasio, Andrea
    Modugno, Nicola
    Paulus, Kai
    Solla, Paolo
    Bandiera, Pasquale
    Croce, Ugo Della
    Deriu, Franca
    Manca, Andrea
    Cugusi, Lucia
    SPORT SCIENCES FOR HEALTH, 2025, : 839 - 851
  • [25] Integration of Virtual Reality into Transcranial Magnetic Stimulation Improves Cognitive Function in Patients with Parkinson's Disease with Cognitive Impairment: A Proof-of-Concept Study
    Cheng, Tsai-Chin
    Huang, Shih-Fong
    Wu, Shang-Yu
    Lin, Fu-Gong
    Lin, Wang-Sheng
    Tsai, Po-Yi
    JOURNAL OF PARKINSONS DISEASE, 2022, 12 (02) : 723 - 736
  • [26] A proof-of-concept, randomized, placebo-controlled, multiple cross-overs (n-of-1) study of naftazone in Parkinson's disease
    Rascol, Olivier
    Ferreira, Joaquim
    Negre-Pages, Laurence
    Perez-Lloret, Santiago
    Lacomblez, Lucette
    Galitzky, Monique
    Lemarie, Jean-Christophe
    Corvol, Jean-Christophe
    Brotchie, Jonathan M.
    Bossi, Laura
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2012, 26 (04) : 557 - 564
  • [27] A smartphone-based tapping task as a marker of medication response in Parkinson's disease: a proof of concept study
    Broeder, Sanne
    Roussos, George
    De Vleeschhauwer, Joni
    D'Cruz, Nicholas
    de Xivry, Jean-Jacques Orban
    Nieuwboer, Alice
    JOURNAL OF NEURAL TRANSMISSION, 2023, 130 (07) : 937 - 947
  • [28] VeCHAT: a proof-of-concept study on screening and managing veterans' mental health and wellbeing
    Goodyear-Smith, Felicity
    Darragh, Margot
    Warren, Jim
    JOURNAL OF PRIMARY HEALTH CARE, 2021, 13 (01) : 75 - 83
  • [29] A proof-of-concept study with SOM3355 (bevantolol hydrochloride) for reducing chorea in Huntington's disease
    Gamez, Josep
    Calopa, Matilde
    Munoz, Esteban
    Ferre, Aileen
    Huertas, Oscar
    McAllister, Kevin
    Reig, Nuria
    Scart-Gres, Catherine
    Insa, Raul
    Kulisevsky, Jaime
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 89 (05) : 1656 - 1664
  • [30] Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer's disease
    Koronyo, Yosef
    Biggs, David
    Barron, Ernesto
    Boyer, David S.
    Pearlman, Joel A.
    Au, William J.
    Kile, Shawn J.
    Blanco, Austin
    Fuchs, Dieu-Trang
    Ashfaq, Adeel
    Frautschy, Sally
    Cole, Gregory M.
    Miller, Carol A.
    Hinton, David R.
    Verdooner, Steven R.
    Black, Keith L.
    Koronyo-Hamaoui, Maya
    JCI INSIGHT, 2017, 2 (16)